T

Tonix Pharmaceuticals Holding Corp
D

TNXP

0.40110
USD
-0.21
(-33.96%)
Pre Open
Volume
2,727
EPS
-26
Div Yield
-
P/E
-0
Market Cap
74,963,274
OverviewSignalsIdeasNews
Related Instruments
    A
    AKBA
    0.01500
    (0.82%)
    1.84500 USD
    B
    BNGO
    0.00010
    (0.05%)
    0.20010 USD
    I
    INO
    -0.04500
    (-2.46%)
    1.78500 USD
    MRNA
    MRNA
    0.270
    (0.69%)
    39.630 USD
    N
    NVAX
    -0.08000
    (-0.92%)
    8.64000 USD
    V
    VBIV
    0.000000
    (0.00%)
    0.000000 USD
    More
News

Title: Tonix Pharmaceuticals Holding Corp.

Sector: Healthcare
Industry: Biotechnology
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targetingCD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.